(Q40825161)

24 September 2017

1 reference

title

Inhibition of endogenous TNF formation by pentoxifylline (English)

1 reference

24 September 2017

0 references

Zabel P

1 reference

24 September 2017

Schade FU

series ordinal

1 reference

24 September 2017

Schlaak M

series ordinal

1 reference

24 September 2017

publication date

1 April 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

187

1 reference

24 September 2017

issue

3-5

1 reference

24 September 2017

page(s)

447-463

1 reference

Secretory products of macrophages

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Tumor necrosis, cachexia, shock, and inflammation: a common mediator

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Interleukin-1 and its biologically related cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Mononuclear phagocytes and eicosanoids: aspects of their synthesis and biological activities

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Differential effect of oxpentifylline on tumour necrosis factor and interleukin-6 production

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

ARDS, neutrophils, and pentoxifylline

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Oxpentifylline in endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Detection of circulating tumor necrosis factor after endotoxin administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

The biology of interleukin 1 and comparison to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

OKT3 first-dose reaction: association with T cell subsets and cytokine release

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Cachectin: a hormone that triggers acute shock and chronic cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Pentoxifylline in the isolated perfused rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Cachectin: more than a tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Pentoxifylline and wellbeing in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

Pentoxifylline prevents murine cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980356-6

7 January 2021

10.1016/S0171-2985(11)80356-6

Identifiers

DOI

0 references

1 reference